Arbutus Biopharma GAAP EPS of -$0.17 misses by $0.13, revenue of $14.08M beats by $13.47M [Seeking Alpha]
Arbutus Biopharma Corporation (ABUS)
Last arbutus biopharma corporation earnings: 11/6 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.arbutusbio.com/node/5806
Company Research
Source: Seeking Alpha
Strong financial position with cash, cash equivalents and marketable securities of $91.5M as of December 2025. Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up More on Arbutus Biopharma Arbutus Biopharma: LNP Litigation And Imdusiran Drive Near-Term Catalysts Moderna gains as Arbutus/ Genevant settlement removes major financial risk Moderna dealt blows in ongoing patent dispute with Arbutus Seeking Alpha's Quant Rating on Arbutus Biopharma Historical earnings data for Arbutus Biopharma
Show less
Read more
Impact Snapshot
Event Time:
ABUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABUS alerts
High impacting Arbutus Biopharma Corporation news events
Weekly update
A roundup of the hottest topics
ABUS
News
- Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate UpdateGlobeNewswire
- Moderna Settlement And EMA Opinion Reframe mRNA Platform Outlook [Yahoo! Finance]Yahoo! Finance
- Why Moderna (MRNA) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement [Yahoo! Finance]Yahoo! Finance
ABUS
Earnings
- 8/6/25 - Beat
ABUS
Sec Filings
- 3/23/26 - Form 8-K
- 3/23/26 - Form 10-K
- 3/3/26 - Form 8-K
- ABUS's page on the SEC website